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Patients with diabetes mellitus often show symptoms
such as dizziness, tinnitus, and hearing impairment. In
general, hearing loss is sensorineural, which is sometimes
confused with presbycusis, mainly because it develops in
patients older than 40 years of age. Angiopathy and
neuropathy caused by diabetes mellitus have been
considered important factors for the vestibular-cochlear
disorders found in these patients. However, there is
controversy regarding the etiopathogenesis of hearing loss,
as some researchers support that it develops due to
neuropathy, others say it is due to angiopathy, or even a
combination of both. Yet, some researchers believe diabetes
mellitus and hearing loss are part of a genetic syndrome.
We have conducted an extensive bibliographic review to
determine whether there is cause-effect relationship
between diabetes mellitus and hearing loss. We were able
to verify that, despite the large number of studies performed,
there is still a great deal of controversy, and new approaches
are being studied, for example in the field of genetics, which
shows that new paths can be followed to reach a conclusion
on this issue.
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INTRODUCTION
The most frequent causes of vestibular and auditory
abnormalities are attributed to dysfunctions in the metabolism
of carbohydrates, thyroid affections, supra adrenal, and other
different metabolic disorders. Among glucose metabolism
disorders, diabetes mellitus is the affection most commonly
related with auditory disorders 1.
Diabetes mellitus is a genetically determined
metabolic disorder associated with absolute or relative
impairment of insulin and in complete clinical manifestation
is characterized by metabolic affections, vascular and
neuropathic complications. The main objective of treating
patients with diabetes is the prevention of chronic
complications because the disease is not curable but only
controllable. In Brazil, the incidence of chronic complications
of diabetes is quite high. It is estimated that there are five
million subjects with diabetes and half of them are not aware
of the diagnosis. A large number of subjects, especially
children and adolescents, have diagnosis of diabetes made
in face of complications, especially infections 2.
One of the morphological aspects more constant in
diabetes mellitus is diffuse thickness of basal membrane,
which may also happen with vascular endothelium, and it is
named diabetic microangiopathy. It is more evident in skin
capillaries, skeletal muscles, retina, renal glomeruli, and re-
nal medulla. Its pathogenesis is still obscure, but it is clearly
associated with hyperglycemia. Other morphological
affections refer to impairment of both motor and sensorial
nerves of lower limbs, characterized as Schwann cell lesions,
degeneration of myelin and axon damage. The cause of
neuropathy is still very controversial, and it may be related
with diffuse microangiopathy that would affect nourishment
of peripheral nerves 3.
Neuropathy and angiopathy are common affections
in diabetes mellitus. Angiopathy has been observed in small
arteries and skin capillaries, muscle, kidney, retina and
peripheral nerves. The factors that may cause neuropathy
are metabolic disorders (glucose metabolism, lipid metabolism
defects and vitamins). Some researchers referred to the fact
that vascular affections in interfascicular or intrafascicular
branches of vasonbervorum contribute to neuropathy.
Atherosclerosis, however, very common in diabetes mellitus,
can also contribute to neuropathy, owing to interference in
rate of nutrient transfer 4.
Angiopathy may occur both in direct way, interfering
with supply to the cochlea by reducing transport through
the thickened walls of capillaries, and indirectly by the
reduction of flow in vascular pathways, or still, because of
secondary degeneration of 8th cranial nerve 5.
Concerning diabetes mellitus, there are different
opinions about the pathological affections caused in the
auditory system.
According to Nageris et al., the association between
hearing loss and diabetes mellitus has been debated since it
was first reported by Jordao in 1857 6.
In the literature, there are many different types of
hearing loss found in diabetic patients. One of them is
progressive, gradual bilateral sensorineural loss, affecting
especially high frequencies and the elderly. It would be si-
milar to presbyacusis, but with more severe losses than those
expected by aging 5-8. Conversely, there are authors that
report the possibility of having early sensorineural loss 7 and
others that reported hearing loss in low and medium
frequencies 9, 10. Some studies described diabetes as the
possible cause of unilateral sudden loss 4,10,11,, but other authors
did not find the same association 12.
As to incidence of hearing loss in patients with diabe-
tes mellitus, we observed that there is no consensus in the
literature either, ranging from zero to 93% 6.
In view of the reported data, we decided to perform
a literature review to check whether there is really a hearing
loss inherit to diabetes mellitus and to which factors it is
related.
LITERATURE REVIEW
A) Diabetic angiopathy: structural and
ultrastructural aspects
Diabetic angiopathy has been characterized by
endothelial proliferation, accumulation of glucoprotein in the
intima and thickness of basal membrane of capillaries and
small blood vessels. We can also observe fibrotic thickness
of the wall and narrowing of internal auditory artery lumen.
We confirmed accumulation of positive PAS substance
(periodical Schiff acid) on the artery wall, as well as on the
modiolus vessels and vascular stria capillaries 4.
A1) Animal lab experimental studies
The effects of diabetes in the inner ear can be studied
in experimental model by using diabetogenic drugs (alloxan
or streptozocin), in genetically modified animals with diabe-
tes (such as Sabra line rats) by means of total or subtotal
pancreatectomy and still by extraction of anterior hypophysis.
Costa13 (1967) used alloxan to induce diabetes in rats
to assess diabetic angiopathy. They found optical microscopy
with increase in thickness of vessel walls of modiolus, more
marked six months after the induction of diabetes. We did
not observe structural changes to Corti’s organ, in ganglionar
cells or in nervous fibers.
Smith et al.14 (1995) confirmed that diabetic
microangiopathy occurred in the inner ear of rats induced
with the use of streptozocin. In the studied group, there
was quantitative documentation by electron transmission
microscopy of the increase in thickness of capillary basal
membrane of vascular stria, which was not observed in the
control group.
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Raynor et al.15 (1995) also used streptozocin to induce
diabetes mellitus and observed that loss of outer hair cells
was greater in diabetic rats that were simultaneously exposed
to noise.
The use of alloxan or intraperitoneal streptozocin to
induce diabetes in experimental models has been contested
because it did not reflect the real physiological mechanism
of diabetes in human beings because it has genetic origin.
Thus, Nageris et al.6 (1998) used rats of Sabra line who have
the tendency to presenting intolerance to glucose when
submitted to 21 days of rich carbohydrate diet. They
concluded that if there is sensorineural loss associated with
diabetes mellitus, its pathogenesis does not involve damage
to hair cells or stria vascularis.
Triana et al.16 (1991), using rat line (SHR/N-cp –
Spontaneous hypertensive rats/ corpulent), who stated that
this is the only genetic model for non-insulin-dependent
diabetes mellitus, observed significant loss of outer hair cells
in animals that were simultaneously obese and diabetic, when
compared to the control group. However, a similar
experiment was conducted with other authors using the same
animal mode and they concluded that diabetes alone did
not cause significant thickness of basal membrane, but in
combination with obesity and exposure to noise they
presented thickness, which was considered significant 17.
A2) Anatomic pathological study in humans
Willianson & Killo18 (1977), in a review study
mentioned that basal membrane of the capillary is formed
by collagen proteins that are common in the connective
tissue and also in scarring tissues, given that synthesis of
these substances increase in response to a variety of stimuli
and damage. They stated that thickness of basal membrane
of the capillary associated with diabetes is considered a
proliferative response of capillary cells to damage. They
reported that this thickness is attributed to repetitive episodes
of death of endothelial cells and their regeneration (with
retention of necrotic endothelial cells on the basal membrane
and beginning of new layers of the same membrane by
regeneration). They concluded that a great variety of in vivo
and in vitro studies are also consistent with this hypothesis,
suggesting that synthesis of basal membrane and tissue
renovation are increased in diabetes and that degradation of
basal membrane is reduced or damaged.
Jorgensen & Buch9 (1961), in a study with temporal
bones of 32 diabetic subjects of all age ranges, showed that
the main affections are shown in preparations of stria vascularis
blood vessels when stained by PAS periodical Schiff acid – a
staining method that clearly defines the basal membrane,
mesangial matrix and hyalinosis. In this study, we found
massive deposits of PAS on the capillary walls of stria
vascularis, which were 10 to 20 times thicker than the usual,
and had homogeneous or lamellar structure. Abnormalities
were similar to those seen in atherosclerosis, but more
marked, occurring only in the stria vascularis. These authors
observed degeneration in other parts of the labyrinth, but
they corresponded to findings in temporal bones of non-
diabetic people of the same age range. The study confirmed
that angiopathy is not generalized, and it is preferably
directed to some capillary systems of inner ear, such as for
example, stria vascularis. However, based on these
investigation, the authors state that they can not come to
conclusions about the chemical nature of the precipitate,
because many substances are stained by this method. They
reported that affections are typical to diabetes and not specific
for the disease, observing that atherosclerosis is peripherally
reduced, whereas diabetic angiopathy increases its intensity
in the region of small vessels.
Costa13 (1967), in a study conducted with temporal
bone of six subjects that were used in their comparative
study previously reported, have also detected positive PAS
material on the wall of stria vascularis capillaries and modiolus,
in addition to thickness of basal membrane in both sites.
Makishima and Tanaka4 (1971) used the temporal
bone of four subjects and also found impregnation by
periodical Schiff acid on thickness of capitally walls of stria
vascularis and modiolus, which was considered responsible
for narrowing of vessel lumen, more intensively affected by
inner auditory artery.
After these initial data on diabetes mellitus and hearing,
most researchers agreed that primary lesions are angiopathic
4,10,14.
B) Diabetic neuropathy: structural and
audiological aspects
B1) Clinical pathology studies in humans
Makishima & Tanaka4 (1971) described atrophy of
spiral ganglion neurons and demyelization of the 8th cranial
nerve in four diabetic subjects. They showed demyelization
is also the initial lesion of peripheral nerves of diabetes
extremity and that there are indications of abnormalities of
myelin metabolism that may have significant importance in
pathogenesis of diabetic neuropathy. Using optical
microscopy, we observed demyelization of auditory nerve
by defferentation of myelin sheath with small affections to
axon and fibrosis of perineurum, severe atrophy of spiral
ganglion with loss of cell of basal turn and medium turn of
the cochlea, in addition to decrease in number of nervous
fibers on the spiral lamina. Other findings were: reduction of
number of ganglionar cells of ventral and dorsal cochlear
nuclei, small loss of ganglionar cells of superior olivary nucleus,
inferior colliculus and medial geniculate body. In auditory
centers of both temporal bone, they did not detect any
specific affections directly attributed to diabetes mellitus.
B2) Audiological study in human
There are other authors that believe that neuropathy
is the primary lesion of hearing loss, arguing that positive
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PAS material found in the vessel wall is very nonspecific,
found also in other diseases. They conducted an audiometric
study in 20 patients with diabetic peripheral neuropathy
using the control of 32 patients with diabetes mellitus. They
observed that the thresholds of peripheral neuropathy
subjects were also worse than the control group, in all
frequencies. And also that patients aged over 60 years were
worse than both groups. Hearing loss found by them was
normally sensorineural, progressive and more intense when
over the age of 60 years7.
C) Correlation between angiopathy and/or diabetic
neuropathy and hearing loss
Table 1 presented the studies that referred to finding
a relation between diabetes mellitus and hearing loss and
Table 2 presents studies that did not find a correlation
between them.
D) Correlation between genetic affection, diabetes mellitus
and hearing loss
It is known that hearing loss can also have its origin
from genetic mutations, which can be congenital or acquired,
occur in nuclear genes and mitochondria and present
syndromic or non-syndromic episodes. DNA mitochondrial
mutations are transmitted by maternal line, but there may
be spontaneous mutations. As to physiopathogenesis of
hearing loss, there are still many issues and theories 19.
Yamasoba et al20 (1996) presented the following theory:
mitochondria l DNA affection → alteration in microchondril
protein synthesis → alteration in oxiphative phosphorilation
→ reduction in the formation of ATP → alteration of ionic
pumps → alterations in potassium, sodium and calcium →
cell death.
In 1989, a specific genealogical tree was studied by
Lemkes et al.21, in which nine children with diabetes mellitus
also showed hearing loss.
Authors have observed a coinciding loss of variable
severity in each diabetic patients. When the third-generation
line was considered, they detected diabetes and hearing
loss present only in children of affected mothers. This
observation has strongly suggested that heritage is exclusively
maternal, which is a particular characteristics of diseases
associated with mitochondrial DNA mutation.
Newkirk et al.22 (1997) reported in a prospective study
prevalence of diabetes mellitus and maternal inherited
deafness in the population of diabetic patients at Newcastle
Hospital. They reported that this association was a new subtype
of diabetes and that it resulted from substitution of adenine
for guanine at position 3243 of mitochondrial gene tRNALeu(uur).
They also pointed out that this syndrome was originally
identified as a cause of MELAS syndrome (myopathy,
encephalopathy, lactic acidosis and repetitive episodes of
cerebral vascular accident) and that sensorineural hearing loss
was an additional symptom in about 70% of the cases.
In some cases, the same mutation may cause
different phenotypes such as in the case of gene tRNAleu, a
substitution of nucleotide adenine for guanine in locus 3243,
which may cause three different phenotypes: progressive
chronic external ophthalmoplegia, diabetes, maternal-
originated deafness and MELAS syndrome. Clinically, dia-
betes mellitus and maternal inherited deafness are
characterized by insulin-dependent diabetes, which can be
non-insulin dependent at first, but normally evolves to it
because the mitochondrial affection modifies insulin
secretion by the pancreas; patients are thin and less than
40 years of age and hearing loss is normally sensorineural
progressive 19.
Fowler et al.23 (1999) described Diadmoad syndrome
or Wolfram syndrome also as a consequent mutation of
mitochondrial DNA, characterized by diabetes insipidus and
mellitus, optical atrophy and sensorineural hearing loss
starting at childhood.
DISCUSSION
As presented in the literature review, there is not
enough evidence to solidly define diabetes mellitus as a
cause of hearing loss. There is no consensus on any aspect
of this topic, either audiologically or histopathologically.
Clinical experience, in many studies, showed direct
correlation between hearing loss and diabetes, as reported
in Table 1. However, there are other studies with more
subjects and better designed that did not identify this
association (Table 2).
Affection of blood vessels that irrigate the inner ear
and affections that occur in stria vascularis of diabetic patients
are unquestionable facts confirmed by different authors that
believe in the correlation between hearing loss and diabe-
tes, and these affections are strong evidences that diabetes
may cause hearing loss 10,13-15. However, there are others
that do not believe in this association 24.
Some studies indicate that decrease in hearing acuity,
similarly to the one presented in presbyacusis, is greater
than what is expected for the age in elderly and diabetic
patients 8,10,12,22,24. According to them, it is more likely that
we can associated factors that would lead to hearing loss,
such as consequence of vascular abnormalities caused by
diabetes mellitus.
Up to 1960, there were 3 theories about the
pathogenesis of hearing loss caused by diabetes mellitus:
neuropathy, angiopathy and association of both. Currently,
there are significant reasons to believe that the angiopathy
found in diabetic patients contributes to greater evidences
of hearing loss. In favor of this hypothesis we can rely on
histopathological findings of microvascular lesions of the inner
ear, such as thickness of basal membrane of stria vascularis
capillaries, as well as the fact that diffuse vascular affections
caused by diabetes mellitus are well known 4,13-15,25.
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It is known that the main difficulty to conduct inner
ear study is related with difficulty to access histological
assessment, especially in human beings. Moreover, the steps
to preparation of material can also have artifacts, provoking
misinterpretations. The localization of inner ear circulation
makes it difficult to study homeostasis, as well as the
consequences of metabolic disorders. Other factors that
can induce misinterpretation of statistical data are use of
different populations for comparison purposes, lack of good
control group, need to conduct longitudinal studies (owing
to the fact that in transversal studies many times it is not
possible to know if diabetes mellitus precedes hearing loss
or vice-versa). Other important aspect is size of studied
group and the huge universe of variables such as other
diseases, use of drugs, noise exposure, genetic affections.
It is possible that these are the reasons for discrepancy in
results detected among similar studies conducted by
different authors.
Finally, we observed growing interest in hearing loss
caused by genetic affections, many of them related to
mitochondrial DNA mutations. They correspond to 0.5% to
1% of all genetically-based hearing losses, which may be
associated with syndromic presentations. One of the
syndrome presentations is diabetes mellitus associated with
Table 1. List of studies that found correlation between diabetes mellitus and hearing loss.
Author Number Gender Age Type of DM Relation w/ Audiological Control
of Influence Influence Influence of presence of results group
patients of gender of age duration complications
DM
Camisasca et 81 male>fem 29-75; I; present DSN in 46% of the no data
 al. (1950) absent present cases
Jorgensen & 69 52♂G17♀; 16-73; I; w/ retinopathy 41% DSN bilateral Johansen
Buch (1961) absent present absent and nephropathy curve
(1943)
Tota & Bocci 100 39B♂61♀; 11-80; I and II; retinopathy 9dB – 6KHz; Patients w/out DM
(1965) no data present present 15dB – 3KHz, matched
> 61-70 years by gender
Marulo et al. 60 36B♂24♀; 20-49; I and II; retinopathy, DSN in 30% of the Johansen
(1974) no data present present coronaryopathy cases curve
peripheral (1943)
angiopathy
Friedman et 20 8B♂12♀; 22-70; II; peripheral DNS in 55% of the 32 patients
al. (1975) no data present present neuropathy cases matched
retinopathy and use by age
of AB
Taylor & Irwin 77 17B♂21♀; 15-62; I; absent DSN mild below 39
(1978) fem>male present absent 9dB. patients
Ferrer et al. 46 no data 14-40; I; retinopathy and 30dB in at least matches
(1991) present present nephropathy one frequency by age
Cullen & 44 32B♂12♀; mean: 46.9; I; no data 38
Cinamond male>fem  present absent p<0.001 high freq. matched
(1993) by age
and gender
Tay et al. 102 58B♂44♀; 19-80; 59 – I no correlation low and medium matched
(1995) no data absent 43- II / frequencies p<0.001 by gender
present
Dalton et al. 344 no data 43-84; II; No association high frequencies absent
(1998) present absent w/ retinopathy. above 4000Hz
Association w/ nephropathy
Karkalapudi 12575 no association No No data Poor levels of 13.1% prevalence 53461 non
et al. (2003) association creatinine and diabetic
microvascular
disease
DM – Diabetes mellitus; dB – decibels; DSN – sensorineural hearing loss; AB – antibiotics; Johansen Curve (1943) – results of audiometric
exams found by the author in subjects of different age ranges in a specific population.
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maternal-inherited hearing loss, amounting to 1.5% of all
cases of diabetes in Japan and The Netherlands 19.
The investigation of genetic causes has been the
answer to many questions and disagreeing results.
CLOSING REMARKS
In view of current knowledge, there is evidence that
diabetes mellitus may cause hearing loss, but we can not
state that there is clear cause-effect correlation. It is known
that a series of variants may favor the association between
both diseases, but it is necessary to conduct more careful
studies to define the true role of these factors. As seen
before, diabetes mellitus and hearing loss can be dependent
components, or even components of a genetic syndrome
and not dependent one on the other.
According to the analyzed studies, we can conclude
that many questions will be answered by multicenter longi-
tudinal studies with large populations and strict inclusion
and exclusion criteria.
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